Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection Robert C. Shamberger, MD, FACS, Michael P. LaQuaglia,

Slides:

Advertisements

Similar presentations

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Advertisements

Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection Robert C. Shamberger, MD, FACS, Michael P. LaQuaglia,

Photodynamic Laser Therapy for Lesions in the Airway

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Prolonged QTc affects short-term and long-term outcomes in patients with normal left ventricular function undergoing cardiac surgery Nattachai Anantasit,

Thoracoscopic management of postoperative esophageal leak

Ground glass opacity of the lung: The veil that needs lifting

Survival after resection of synchronous non–small cell lung cancer

Operative Results and Outcomes in Children With Shone's Anomaly

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Victor van Berkel, MD, PhD

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

The Journal of Thoracic and Cardiovascular Surgery

How should we treat air leaks?

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

The lord of the rings Antonio Miceli, MD, PhD

Support Your Specialty

James Majeski, MD, PhD, E. Stanley Crawford, MD, Elizabeth I

Innovation and science: The future of valve design

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

It's not “just a shunt” but sometimes it should be…

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response.

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Stephen R. Broderick, MD, MPHS

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Nilto Carias de Oliveira, MD, Tirone E

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

The Ross procedure: Time to reevaluate the guidelines

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Pulmonary Resection for Metastases from Colorectal Cancer

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation Bryan F. Meyers, MD, Roger D. Yusen,

Carcinoma of the esophagus: Prognostic significance of histologic type

James I. Fann, MD, John E. Connolly, MD

Superior sulcus lung tumors: Impact of local control on survival

Michael A. Coady, MD, John A. Rizzo, PhD, Graeme L

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tai Ji: The law of inflammatory response

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Thoracic impalement after ultralight aircraft crash

The continuing challenge of congenital heart disease in China

Building a clinical program in a single institution

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

First in line for robotic surgery: Would you want to know?

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

James A. DeWeese, MD Journal of Vascular Surgery

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Debunking dogma: The arduous task of writing AATS consensus guidelines

How do we follow up our patients

Acquired aortopulmonary fistula in acute dissection

Edward Y. Chan, MD, Michael J. Reardon, MD

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Ewing sarcoma of the ribResults of an intergroup study with analysis of outcome by timing of resection Robert C. Shamberger, MD, FACS, Michael P. LaQuaglia, MD, FACS, Mark D. Krailo, PhD, James S. Miser, MD, Douglas J. Pritchard, MD, Mark C. Gebhardt, MD, FACS, John H. Healey, MD, Nancy J. Tarbell, MD, Christopher J.H. Fryer, MD, Paul A. Meyers, MD, Holcombe E. Grier, MD The Journal of Thoracic and Cardiovascular Surgery Volume 119, Issue 6, Pages 1154-1161 (June 2000) DOI: 10.1067/mtc.2000.106330 Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Kaplan-Meier estimate of EFS for all patients with nonmetastatic disease at study entry (n = 393). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1154-1161DOI: (10.1067/mtc.2000.106330) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Kaplan-Meier estimates of EFS for patients with nonmetastatic disease at study entry according to site of primary tumor (P = .03): ribs (n = 53), humerus or femur (n = 100), pelvis (n = 93), or other site (n = 147). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1154-1161DOI: (10.1067/mtc.2000.106330) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 Kaplan-Meier estimates of EFS for patients with nonmetastatic rib primary tumors according to estimated tumor volume (P = .03): 419 cm3 or less or greater than 420 cm3. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1154-1161DOI: (10.1067/mtc.2000.106330) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 4 Kaplan-Meier estimates of EFS for patients with nonmetastatic rib primary tumors according to age at study entry (P = .01): 10 years or younger (n = 19), 10 to 17 years (n = 30), or older than 17 years (n = 4). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1154-1161DOI: (10.1067/mtc.2000.106330) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 5 Kaplan-Meier estimates of EFS for patients with nonmetastatic rib primary tumors according to whether the operation was conducted before the start of systemic chemotherapy (P = .5): yes (n = 16) versus no (n = 35). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1154-1161DOI: (10.1067/mtc.2000.106330) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 6 Kaplan-Meier estimates of EFS after local control for patients with nonmetastatic rib primary tumors according to type of local control (P = .3): radiation therapy (n = 14), an operation (n = 18), or radiation therapy and an operation (n = 12). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1154-1161DOI: (10.1067/mtc.2000.106330) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions